147011-41-4 Usage
Uses
Used in Pharmaceutical Research:
1-[2-(Bromomethyl)-1,3-dioxolan-2-yl]-N-(phenylmethyl)cyclopropanecarboxamide is used as a key intermediate in the synthesis of pharmaceuticals for its potential antiviral, anticancer, and anticonvulsant properties. The presence of the bromomethyl group allows for further functionalization and the creation of new drug candidates with improved pharmacological profiles.
Used in Organic Synthesis:
In the field of organic synthesis, 1-[2-(Bromomethyl)-1,3-dioxolan-2-yl]-N-(phenylmethyl)cyclopropanecarboxamide serves as a versatile building block. Its dioxolane ring and cyclopropane carboxamide group provide opportunities for the development of novel chemical entities with diverse biological activities, contributing to the advancement of organic chemistry and the discovery of new therapeutic agents.
Used in Drug Discovery:
1-[2-(Bromomethyl)-1,3-dioxolan-2-yl]-N-(phenylmethyl)cyclopropanecarboxamide is utilized in drug discovery as a valuable compound for exploring new chemical space. Its complex structure and functional groups enable researchers to investigate its interactions with biological targets, potentially leading to the identification of new lead compounds for the treatment of various diseases.
Used in Understanding Disease Pathways:
1-[2-(Bromomethyl)-1,3-dioxolan-2-yl]-N-(phenylmethyl)cyclopropanecarboxamide is also used in biological research to probe the mechanisms of action of cyclopropane carboxamides and their potential role in treating diseases. By studying the interactions of 1-[2-(Bromomethyl)-1,3-dioxolan-2-yl]-N-(phenylmethyl)cyclopropanecarboxamide with cellular components, researchers can gain insights into the molecular basis of diseases and identify new therapeutic targets.
Check Digit Verification of cas no
The CAS Registry Mumber 147011-41-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,7,0,1 and 1 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 147011-41:
(8*1)+(7*4)+(6*7)+(5*0)+(4*1)+(3*1)+(2*4)+(1*1)=94
94 % 10 = 4
So 147011-41-4 is a valid CAS Registry Number.
InChI:InChI=1/C15H18BrNO3/c16-11-15(19-8-9-20-15)14(6-7-14)13(18)17-10-12-4-2-1-3-5-12/h1-5H,6-11H2,(H,17,18)
147011-41-4Relevant academic research and scientific papers
Synthesis and antibacterial activities of novel oxazolidinones having spiro[2,4]heptane moieties
Kim, So-Young,Park, Hyeong Beom,Cho, Jung-Hyuck,Yoo, Kyung Ho,Oh, Chang-Hyun
scheme or table, p. 2558 - 2561 (2010/03/03)
The synthesis of a new series of oxazolidinones having spiro[2,4]heptane moieties is described. Their in vitro antibacterial activities against both Gram-positive and Gram-negative bacteria were tested and the effect of substituents on the oxazolidinone ring was investigated. A particular compound Ih having fluoro group showed the most potent antibacterial activity.
Synthesis and In-Vitro Activity of Novel 1β-Methylcarbapenems Having Spiro[2,4]heptane Moieties
Park, Hyeong Beom,Jo, Nam Hyun,Hong, Joon Hee,Chei, Jung Hoon,Cho, Jung-Hyuck,Yoo, Kyung Ho,Oh, Chang-Hyun
, p. 530 - 537 (2008/12/21)
The synthesis of a new series of 1β-methylcarbapenems having spiro[2,4]heptane moieties is described. Their in-vitro antibacterial activities against both gram-positive and gram-negative bacteria were tested and the effect of substituents on the pyrrolidine ring was investigated. Most compounds were shown to be more active than the compared meropenem and imipenem against Escherichia coli. One particular compound, IIIb, having hydroxy a moiety showed the most potent antibacterial activity.
